Showing results 20 to 39 of 60
< previous
next >
| Preview | Issue Date | Title | Author(s) |
| 1998 | Genetic and environmental origins of polycyctic ovary syndrome | Norman, R.; Huber Buchholz, M.M.; Hague, W. |
| 2009 | Genetic susceptibility to viral exposure may increase the risk of cerebral palsy | Djukic, M.; Gibson, C.; MacLennan, A.; Goldwater, P.; Haan, E.; McMichael, G.; Priest, K.; Dekker, G.; Hague, W.; Chan, A.; Rudzki, Z.; van Essen, P.; Khong, T.; Morton, M.; Ranieri, E.; Scott, H.; Tapp, H.; Casey, G. |
| 2010 | Glycemia and its relationship to outcomes in the metformin in Gestational Diabetes Trial | Rowan, J.; Gao, W.; Hague, W.; McIntyre, H. |
| 2003 | Homocysteine and pregnancy | Hague, W. |
| 1996 | Hyperinsulinemia is common in family members of women with polycystic ovary syndrome | Norman, R.; Masters, S.; Hague, W. |
| 2002 | Hypertension in pregnancy : round-table discussion: part 1: cardiovascular profile | Brink, A.; Akande, W.; Moodley, J.; Hague, W.; Hall, D.; Steyn, W.; Dekker, G.; Odendaal, H. |
| 2005 | Immediate blood pressure changes and aquatic physiotherapy | Ward, E.; McIntyre, A.; Van Kessel, G.; Hague, W. |
| 2010 | Increased lymphocyte micronucleus frequency in early pregnancy is associated prospectively with pre-eclampsia and/or intrauterine growth restriction | Furness, D.; Dekker, G.; Hague, W.; Khong, T.; Fenech, M. |
| 2008 | Inherited thrombophilia and pregnancy complications revisited | Rodger, M.; Paidas, M.; McLintock, C.; Middeldorp, S.; Kahn, S.; Martinelli, I.; Hague, W.; Montella, K.; Greer, I. |
| 2013 | Interventions for treating cholestasis in pregnancy | Gurung, V.; Middleton, P.; Milan, S.; Hague, W.; Thornton, J. |
| 2007 | Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: Substudy of a randomized controlled trial | Rodger, M.; Kahn, S.; Cranney, A.; Hodsman, A.; Kovacs, M.; Clement, A.; Lazo-langner, A.; Hague, W. |
| 2010 | Long-term follow-up of women with gestational diabetes mellitus: The South Australian Gestational Diabetes Mellitus Recall Register | Chittleborough, C.; Baldock, K.; Taylor, A.; Hague, W.; Willson, T.; Martin, W.; Wood, J.; Phillips, P. |
| 2012 | Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT | de Vries, J.; van Pampus, M.; Hague, W.; Bezemer, P.; Joosten, J. |
| 2013 | Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset preeclampsia in women with antiphospholipid antibodies | Van Hoorn, M.; Hague, W.; Van Pampus, M.; Bezemer, P.; De Vries, J.; 24th Congress of the International Society on Thrombosis and Haemostasis (29 Jun 2013 - 4 Jul 2013 : Amsterdam, The Netherlands) |
| 2013 | Maternal and neonatal circulating markers of metabolic and cardiovascular risk in the Metformin in Gestational Diabetes (MiG) trial: Responses to maternal metformin versus insulin treatment | Barrett, H.; Gatford, K.; Houda, C.; De Blasio, M.; McIntyre, H.; Callaway, L.; Nitert, M.; Coat, S.; Owens, J.; Hague, W.; Rowan, J. |
| 1995 | Metabolic approaches to the subclassification of Polycystic Ovary Syndrome | Norman, R.; Masters, S.; Hague, W.; Beng, C.; Pannall, P.; Wang, J. |
| 2021 | Metformin for preventing type 2 diabetes mellitus in women with a previous diagnosis of gestational diabetes: a narrative review | Versace, V.L.; Beks, H.; Wesley, H.; McNamara, K.; Hague, W.; Anjana, R.M.; Mohan, V.; Khunti, K.; Dunbar, J.A. |
| 2013 | Metformin for women who are obese during pregnancy for improving maternal and infant outcomes | Eames, A.; Grivell, R.; Deussen, A.; Hague, W.; Dodd, J. |
| 2011 | Metformin in gestational diabetes: The Offspring Follow-Up (MiG TOFU): body composition at 2 years of age | Rowan, J.; Rush, E.; Obolonkin, V.; Battin, M.; Wouldes, T.; Hague, W. |
| 2007 | Metformin in pregnancy and lactation | Hague, W. |
